These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35640765)

  • 1. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer.
    Gupta U; Saren BN; Khaparkhuntikar K; Madan J; Singh PK
    J Control Release; 2022 Aug; 348():1089-1115. PubMed ID: 35640765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective.
    Harwansh RK; Bahadur S; Deshmukh R; Rahman MA
    Curr Pharm Des; 2020; 26(11):1191-1205. PubMed ID: 32003686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics.
    Date T; Nimbalkar V; Kamat J; Mittal A; Mahato RI; Chitkara D
    J Control Release; 2018 Feb; 271():60-73. PubMed ID: 29273320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
    Rajpoot K
    Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-drug delivery system: a promising approach against breast cancer.
    Malik JA; Ansari JA; Ahmed S; Khan A; Ahemad N; Anwar S
    Ther Deliv; 2023 May; 14(5):357-381. PubMed ID: 37431741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers.
    Gopalan D; Pandey A; Udupa N; Mutalik S
    J Control Release; 2020 Mar; 319():183-200. PubMed ID: 31866505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.
    Ansari MA; Thiruvengadam M; Farooqui Z; Rajakumar G; Sajid Jamal QM; Alzohairy MA; Almatroudi A; Alomary MN; Chung IM; Al-Suhaimi EA
    Semin Cancer Biol; 2021 Feb; 69():109-128. PubMed ID: 31891780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid based nanocarriers: a translational perspective.
    Mishra DK; Shandilya R; Mishra PK
    Nanomedicine; 2018 Oct; 14(7):2023-2050. PubMed ID: 29944981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers.
    Keyvani V; Mollazadeh S; Riahi E; Mahmoudian RA; Tabari M; Lagzian E; Ghorbani E; Akbarzade H; Gholami AS; Gataa IS; Hassanian SM; Ferns GA; Khazaei M; Avan A; Anvari K
    Curr Pharm Des; 2024; 30(13):975-987. PubMed ID: 38500284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer.
    Zheng Y; Li M; Weng B; Mao H; Zhao J
    Biomater Sci; 2022 Mar; 10(7):1607-1625. PubMed ID: 35188522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells.
    Fatima Qizilbash F; Sartaj A; Qamar Z; Kumar S; Imran M; Mohammed Y; Ali J; Baboota S; Ali A
    J Drug Target; 2023 Sep; 31(8):794-816. PubMed ID: 37525966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-based Nanocarriers Loaded with Taxanes for the Management of Breast Cancer: Promises and Challenges.
    Chaurawal N; Misra C; Raza K
    Curr Drug Targets; 2022; 23(6):544-558. PubMed ID: 34431461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics.
    Garg NK; Singh B; Jain A; Nirbhavane P; Sharma R; Tyagi RK; Kushwah V; Jain S; Katare OP
    Colloids Surf B Biointerfaces; 2016 Oct; 146():114-26. PubMed ID: 27268228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites.
    Cao J; Huang D; Peppas NA
    Adv Drug Deliv Rev; 2020 Dec; 167():170-188. PubMed ID: 32622022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer.
    Rajana N; Mounika A; Chary PS; Bhavana V; Urati A; Khatri D; Singh SB; Mehra NK
    J Control Release; 2022 Dec; 352():1024-1047. PubMed ID: 36379278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms.
    Falagan-Lotsch P; Grzincic EM; Murphy CJ
    Bioconjug Chem; 2017 Jan; 28(1):135-152. PubMed ID: 27973767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates.
    Choudhury H; Pandey M; Wen LP; Cien LK; Xin H; Yee ANJ; Lee NJ; Gorain B; Amin MCIM; Pichika MR
    Curr Pharm Des; 2020; 26(42):5365-5379. PubMed ID: 32693762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics.
    Jahan S; Karim ME; Chowdhury EH
    Biomedicines; 2021 Jan; 9(2):. PubMed ID: 33530291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.